-
TIL Therapy Amplifies the Immune System’s Attack on MelanomaThe recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
by Sandra Gordon
-
Facts and Stats
Breast Cancer Survival Rates Continue to RiseNew report highlights decades of progress, as well as a persisting disparity.
by Thomas Celona
-
Taking a Shot Against Cancer RecurrencesEarly findings on therapeutic vaccines suggest they can delay or stop cancer from returning after tumors are surgically removed.
by Kendall K. Morgan
-
Forward Look
Preventing Blood ClotsMedical oncologist Michael B. Streiff discusses new guidelines to reduce the risk of life-threatening blood clots.
by Ashley P. Taylor
-
Forward Look
The Late Effects of Childhood CancerAlmost all childhood cancer survivors will develop significant health problems related to their treatment by age 45.
by Suzanne McBride
-
Forward Look
Non-surgical Options in Bladder CancerSome people with muscle-invasive cancer can forgo bladder removal surgery.
by Darcy Lewis
-
From the Editor-in-Chief
Early-onset Colorectal Cancer on the RiseResearchers search for reasons for the growing number of cases in people under 50.
by William G. Nelson, MD, PhD
-
CAR T-cell Therapy: Understanding the Warning and the RisksThe FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?
by Sandra Gordon
-
The More You Know About Cancer PreventionStudies found awareness gaps about cancer prevention strategies such as screening and vaccination may reduce benefits from these tactics.
by Cancer Research Catalyst
-
Emerging Treatments for Brain Metastases in Breast CancerSABCS panel describes advances and pivotal questions in managing patients whose breast cancer has metastasized to their brain.
by Marci A. Landsmann
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
